A double-blind randomised control trial of peripheral blood eosinophils to direct prednisolone use in COPD exacerbations Source: Annual Congress 2011 - Mechanism and monitoring of airway diseases Year: 2011
Blood eosinophils in COPD: long term variability and clinical outcomes Source: International Congress 2017 – Innovation in COPD: techniques and facts Year: 2017
Impact of blood eosinophil variability in asthma: a real-life population study. Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021
A prospective study comparing the repeatability and sensitivity to change of non-invasive endpoints in pulmonary arterial hypertension: the RESPIRE study Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension Year: 2019
Cilomilast reduces CD8+ T-lymphocytes and macrophages in patients with chronic obstructive pulmonary disease (COPD): a double-blind placebo-controlled, parallel-group quantitative study of bronchial biopsies Source: Eur Respir J 2001; 18: Suppl. 33, 338s Year: 2001
Neutrophil-to-lymphocyte ratio, blood eosinophils and COPD exacerbations: a cohort study Source: ERJ Open Res, 7 (4) 00471-2021; 10.1183/23120541.00471-2021 Year: 2021
Real-world effectiveness of omalizumab in allergic asthma patients with low or high blood eosinophils: A retrospective claims analysis study Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018
Repeatability study comparing plethysmographic and spirometric lung function parameters in COPD patients, asthmatics, and healthy subjects Source: Eur Respir J 2006; 28: Suppl. 50, 221s Year: 2006
QVA149 compared with salmeterol/fluticasone (SFC) on exacerbations and its correlation with baseline blood eosinophils: A pooled analysis of LANTERN and ILLUMINATE Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015
Quality of diffusion measurement in a multicenter clinical trial with moderate to severe COPD patients with emphysema Source: Annual Congress 2010 - Quality measurement and improvement in lung function Year: 2010
LATE-BREAKING ABSTRACT: Intra-day symptoms fluctuations: STORICO, observational study on the characterization of 24-hour symptoms in COPD patients Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases Year: 2016
Late Breaking Abstract - Continuous positive airway pressure (CPAP) as an intervention for acute hypoxia in not-for-escalation (NFE) COVID-19 pneumonia patients: a single-centre observational study with retrospective cohort analysis Source: Virtual Congress 2020 – COVID-19 clinical studies Year: 2020
LATE-BREAKING ABSTRACT: Effect of CPAP treatment on blood pressure levels in resistant hypertension. A multicenter randomized study from the Spanish sleep network (NCT00616265) Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012
The influence of lung volume reduction surgery on exercise in patients with COPD Source: Eur Respir J 2004; 23: 269-274 Year: 2004
A multicentre randomised controlled trial of inspiratory muscle training for patients with chronic obstructive pulmonary disease (IMTCO study) Source: International Congress 2017 – Exercise training and breathing exercises in chronic respiratory disease Year: 2017
LVRS improves endothelial function and blood pressure in patients with COPD: A randomized-controlled trial Source: International Congress 2015 – Multidimensional analysis of respiratory problems Year: 2015
Prospective cohort study of patients complaining of high pressure with CPAP/APAP (PAP) who switch to bi-level PAP (VAuto) as second-line therapy: POP-IN study Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019
LATE-BREAKING ABSTRACT: COPD-associated severe pulmonary hypertension (COPDPH): results of a 16-weeks prospective multicenter, double-blind, placebo-controlled randomized clinical trial (RCT) [SPHERIC-1 (http://clinicaltrials.gov/ct2/show/NCT01441934)] investigating the effect of sildenafil citrate (Sld) on pulmonary vascular resistance (PVR) and PaO2. Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013
Quality of Helium dilution lung volume measurement in a multicenter clinical trial with moderate to severe COPD patients with emphysema Source: Annual Congress 2010 - Quality measurement and improvement in lung function Year: 2010
Heliox and alveolar oxygenation in patients with chronic obstructive pulmonary disease: a multicentre, randomised, crossover study Source: Eur Respir J 2004; 24: Suppl. 48, 243s Year: 2004